Usense logo — Precision health monitoring through AI-powered urine analysi...

Usense

Precision health monitoring through AI-powered urine analysis for early diagnosis and continuous pathology tracking in medical consultations and emergencies.

Founded 2019 11-50 employees Series A Total: $8.85M Analytics, Health Care +1

General Information

Company Name Usense
Founded Year 2019
Employees 11-50
Industries Analytics, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Usense. To contact Usense, visit usense.healthcare.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Usense

Usense is a Medtech startup founded in 2019, aiming to revolutionize precision health monitoring through AI-powered urine analysis. The company's slogan emphasizes its focus on early diagnosis and continuous pathology tracking in medical consultations and emergencies. Usense's innovative approach involves providing precise measurement of health parameters traditionally analyzed in medical biology laboratories through urine samples, leveraging AI and machine learning. The latest milestone for Usense was a significant €5.00M Series A investment received on 04 October 2021. This funding round, although lacking specified investors, showcases growing interest and confidence in the potential of Usense's disruptive technology. With a primary focus on Analytics and Health Care, Usense is strategically positioned to address critical needs in the medical industry and potentially make a significant impact on patient care and outcomes.

Taxonomy: Precision health monitoring, AI-powered urine analysis, Medtech, Early diagnosis, Machine learning, Emergency medicine, Pathology tracking, Health parameters measurement, Personalized medicine, Predictive medicine

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €5.00M -
04 Oct 2021
Grant €3.55M -
15 Jun 2021
Non Equity Assistance Undisclosed 1
AGORANOV
01 May 2021
Seed Round €300.00K -
04 Sep 2020

Usense Alternatives & Competitors

Usense vs
Starling (YC W22)
Starling (YC W22) United States

An AI-powered at home urology remote patient monitoring platform

Seed
12 employees
Health Care, Medical Devices
Usense vs
Cardiolyse
Cardiolyse Finland

Medical-grade Heart Health AI

11 employees
Analytics, Digital Health
Usense vs
Lab Me Analytics
Lab Me Analytics United States

Affordable & Highly Accurate At-Home Blood Testing & Predictive Analytics

Seed
2 employees
AI, Analytics

FAQ About Usense

Precision health monitoring through AI-powered urine analysis for early diagnosis and continuous pathology tracking in medical consultations and emergencies.
Usense was founded in 2019.
Usense operates in Analytics, Health Care and Medical Devices. Its work centres on Precision health monitoring, AI-powered urine analysis, Medtech and Early diagnosis.
Usense has approximately 11-50 employees.
Usense has completed 4 funding rounds, raising a total of $8.85M. The latest funding stage is Series A.
Top alternatives and competitors to Usense include Starling (YC W22), Cardiolyse, Lab Me Analytics, Predict4Health, Olive Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Usense and Starling (YC W22) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Usense, https://bouncewatch.com/company/usense, updated 4 August 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes